Form 8-K - Current report:
SEC Accession No. 0001558370-25-010770
Filing Date
2025-08-07
Accepted
2025-08-07 16:17:03
Documents
14
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20250807x8k.htm   iXBRL 8-K 45701
2 EX-99.1 tmb-20250807xex99d1.htm EX-99.1 203217
  Complete submission text file 0001558370-25-010770.txt   381250

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20250807.xsd EX-101.SCH 3972
4 EX-101.DEF tmb-20250807_def.xml EX-101.DEF 2803
5 EX-101.LAB tmb-20250807_lab.xml EX-101.LAB 16544
6 EX-101.PRE tmb-20250807_pre.xml EX-101.PRE 9652
16 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250807x8k_htm.xml XML 4633
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 251194290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)